Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-12-03

Clinical Trial Update: Spironolactone to Decrease Potassium Wasting in Hypercalciurics on Thiazides Diuretics [NA]

View source ↗

Summary

This completed clinical trial update evaluates whether spironolactone reduces potassium wasting in individuals with idiopathic hypercalciuria who are taking thi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Spironolactone (spironolactone)

Snippet

Sponsor: Indiana University School of Medicine | Conditions: Idiopathic Hypercalciuria, Hypokalemia Caused by Thiazide Diuretics | NA | Status: COMPLETED